Scarica l'app Stockscreener
83.50
0.31%
0.26
Pre-mercato:
81.83
-1.67
-2.00%
Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline - AOL.com
B Group Discloses New Position in Bright Minds Biosciences - HarianBasis.co
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline - The Motley Fool
Bright Minds Biosciences Stock Jumps After $220 Piper Sandler Call—What DRUG Traders Are Watching - Bez Kabli
Piper Sandler raises Bright Minds stock price target on program progress - Investing.com UK
Piper Sandler Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Raises Target Price to $220 - Moomoo
Piper Sandler raises Bright Minds stock price target on program progress By Investing.com - Investing.com South Africa
Bright Minds Biosciences Boosts Cash Reserves as R&D Losses Widen in Q2 2026 Filing - TipRanks
[6-K] BRIGHT MINDS BIOSCIENCES INC. Current Report (Foreign Issuer) | DRUG SEC FilingForm 6-K - Stock Titan
Vestal Point (DRUG) and Ryan Wilder report 492,319 shares, 5% stake - Stock Titan
Janus Henderson (DRUG) discloses 1.28M shares, 13.1% stake - Stock Titan
Janus Henderson Group (DRUG) discloses 1.28M shares, 13.1% stake - Stock Titan
Bright Minds Biosciences Inc. (DRUG) Eps Diluted (TTM) - Zacks Investment Research
Vivo entities disclose 504,645 shares in Bright Minds Biosciences (DRUG) - Stock Titan
TradingKey - TradingKey
Bright Minds Biosciences Inc expected to post a loss of C$1.19 a shareEarnings Preview - TradingView
Bright Minds Biosciences (DRUG) to Release Earnings on Friday - MarketBeat
Trading Systems Reacting to (DRUG) Volatility - Stock Traders Daily
This Insider Has Just Sold Shares In Bright Minds Biosciences - simplywall.st
DRUG SEC FilingsBright Minds Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Cormorant sells $9.78m in Bright Minds Biosciences stock - Investing.com UK
Cormorant sells $9.78m in Bright Minds Biosciences stock By Investing.com - Investing.com Australia
[SCHEDULE 13G/A] BRIGHT MINDS BIOSCIENCES INC. Amended Passive Investment Disclosure - Stock Titan
Insider Selling: Bright Minds Biosciences (NASDAQ:DRUG) Major Shareholder Sells 109,331 Shares of Stock - MarketBeat
Bright Minds Biosciences(DRUG.US) Insider Sells US$9.79 Million in Common Stock - Moomoo
Bright Minds Biosciences (DRUG) holder sells 109,331 shares in open market - Stock Titan
Bright Minds announces ATM offering up to $100 million - MSN
How Bright Minds Biosciences Inc. (DRUG) Affects Rotational Strategy Timing - Stock Traders Daily
Bright Minds (DRUG) Year-Ahead Outlook | Q4 2025: Earnings ReportSurprise Score - Cổng thông tin điện tử tỉnh Tây Ninh
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Top 3 Canadian Biotech Stocks in 2026 - Investing News Network
Bright Minds Biosciences (NASDAQ:DRUG) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Shroom stocks rise as Trump is said to sign executive order on psychedelic drug - Seeking Alpha
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Growth in Short Interest - MarketBeat
(DRUG) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at Jefferies Financial Group - MarketBeat
Jefferies initiates Bright Minds stock with buy on epilepsy drug By Investing.com - Investing.com South Africa
Jefferies initiates Bright Minds stock with buy on epilepsy drug - Investing.com
Total debt per share of Bright Minds Biosciences Inc. – NEO:DRUG - TradingView
Certain RSUs of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com
Certain Options of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com
2.98%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):